Molecular mimicry and cancer vaccine development

Molecular mimicry and cancer vaccine development

Abstract Background The development of cancer immunotherapeutic strategies relies on the identification and validation of optimal target tumor antigens, which should be tumor-specific as well as able to elicit a swift and potent anti-tumor immune response. The vast majority of such strategies are ba...

Full description

Bibliographic Details
Main Authors: Maria Tagliamonte, Beatrice Cavalluzzo, Angela Mauriello, Concetta Ragone, Franco M. Buonaguro, Maria Lina Tornesello, Luigi Buonaguro
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Molecular Cancer
Subjects:
Tumor-Associated Antigens
Microbiota
Cancer Vaccines
Molecular Mimicry
T cell cross-reactivity
Online Access:https://doi.org/10.1186/s12943-023-01776-0

Internet

https://doi.org/10.1186/s12943-023-01776-0

Similar Items